QTTB: Q32 Bio Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 3 sales totaling $45K in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-06 | Morrison Jodie Pope | CEO | $27K | |
| 2026-10-06 | Violette Shelia M. | Officer | $8K | |
| 2026-10-06 | Kalowski Lee | CFO | $11K |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-10-09 | New 13G stake | Frazier Life Sciences Public Fund, L.P. | 5.90% | SEC | |
| 2026-08-14 | Fell below 5% | Point72 Asset Management, L.P. | 4.95% | SEC | |
| 2026-08-14 | Fell below 5% | Sirenia Capital Management LP | 0.00% | SEC | |
| 2026-07-31 | 13G amendment | Opaleye Management Inc. | 5.49% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.